Cargando…

Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer

The role of transglutaminase type 2 in cell physiology is related to protein transamidation and signal transduction (affecting extracellular, intracellular and nuclear processes) aided by the expression of truncated isoforms and of two lncRNAs with regulatory functions. In breast cancer TG2 is assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguiari, Gianluca, Crudele, Francesca, Taccioli, Cristian, Minotti, Linda, Corrà, Fabio, Keillor, Jeffrey W., Grassilli, Silvia, Cervellati, Carlo, Volinia, Stefano, Bergamini, Carlo M., Bianchi, Nicoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692156/ https://www.ncbi.nlm.nih.gov/pubmed/34975314 http://dx.doi.org/10.7150/ijbs.64167

Ejemplares similares

The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2
por: Bianchi, Nicoletta, et al.
Publicado: (2021)

Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells
por: Bergamini, Carlo M., et al.
Publicado: (2021)

A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K(+) Channel in Breast Cancer
por: Canella, Rita, et al.
Publicado: (2022)

Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines
por: Terrazzan, Anna, et al.
Publicado: (2023)

UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines
por: Corrà, Fabio, et al.
Publicado: (2021)

The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma
por: Crudele, Francesca, et al.
Publicado: (2021)

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype
por: Gates, Eric W. J., et al.
Publicado: (2023)

A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum
por: Almugadam, Shawgi Hago, et al.
Publicado: (2023)

Circulating microRNAs Suggest Networks Associated with Biological Functions in Aggressive Refractory Type 2 Celiac Disease
por: Bianchi, Nicoletta, et al.
Publicado: (2022)

The Network of Non-coding RNAs in Cancer Drug Resistance
por: Corrà, Fabio, et al.
Publicado: (2018)

SNPs and Somatic Mutation on Long Non-Coding RNA: New Frontier in the Cancer Studies?
por: Minotti, Linda, et al.
Publicado: (2018)

The network of non-coding RNAs and their molecular targets in breast cancer
por: Crudele, Francesca, et al.
Publicado: (2020)

A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
por: Kim, Soo-Youl, et al.
Publicado: (2020)

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
por: Agnoletto, Chiara, et al.
Publicado: (2019)

Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
por: Baldassari, Federica, et al.
Publicado: (2018)

Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells
por: Caron, Nicholas S., et al.
Publicado: (2012)

Design of a glutamine substrate tag enabling protein labelling mediated by Bacillus subtilis transglutaminase
por: Oteng-Pabi, Samuel K., et al.
Publicado: (2018)

Machine Learning Algorithms Highlight tRNA Information Content and Chargaff’s Second Parity Rule Score as Important Features in Discriminating Probiotics from Non-Probiotics
por: Bergamini, Carlo M., et al.
Publicado: (2022)

Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study
por: Galasso, Marco, et al.
Publicado: (2016)

Differential expression of microRNA501-5p affects the aggressiveness of clear cell renal carcinoma
por: Mangolini, Alessandra, et al.
Publicado: (2014)

Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
por: Fisher, Matthew L., et al.
Publicado: (2015)

Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase
por: Gates, Eric W. J., et al.
Publicado: (2023)

Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
por: McConoughey, Stephen J, et al.
Publicado: (2010)

Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation
por: Colak, Gozde, et al.
Publicado: (2011)

Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation
por: Adhikary, Gautam, et al.
Publicado: (2018)

New Therapeutic Interventions for Kidney Carcinoma: Looking to the Future
por: Dell’Atti, Lucio, et al.
Publicado: (2022)

Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women
por: Tisato, Veronica, et al.
Publicado: (2017)

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas
por: Barbano, Raffaela, et al.
Publicado: (2014)

Deletion or Inhibition of Astrocytic Transglutaminase 2 Promotes Functional Recovery after Spinal Cord Injury
por: Elahi, Anissa, et al.
Publicado: (2021)

AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL
por: Stankiewicz, Monika J., et al.
Publicado: (2013)

Plasma Vascular Endothelial Growth Factor Dysregulation in Defining Aggressiveness of Head and Neck Squamous Cell Carcinoma
por: Kulapaditharom, Boonchu, et al.
Publicado: (2012)

Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates Osteoblast Matrix Secretion and Deposition by Affecting Microtubule Dynamics
por: Al-Jallad, Hadil F., et al.
Publicado: (2011)

Cardiovascular Aggression by Doxorubicin: The Search for Mechanisms
por: Martins, Wolney de Andrade
Publicado: (2018)

Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2
por: Jambrovics, Károly, et al.
Publicado: (2020)

GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials
por: Tili, Esmerina, et al.
Publicado: (2010)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
por: Agnoletto, Chiara, et al.
Publicado: (2018)

MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency
por: Fong, Louise Y., et al.
Publicado: (2016)

The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model
por: García-Cruz, Roseli, et al.
Publicado: (2015)

Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation
por: Jambrovics, Károly, et al.
Publicado: (2019)

Selected MicroRNAs Define Cell Fate Determination of Murine Central Memory CD8 T Cells
por: Almanza, Gonzalo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_40mf1piec60ebcfc1hr901qt44